Clinical trial Recruiting at 1 site Interventional Ages 1 Day to 8 Months

Comparing breathing support methods for preterm infants

Official title: Effect of Nasal Continuous Positive Airway Pressure (nCPAP) Versus Non-Invasive Positive Pressure Ventilation (NIPPV) On Diaphragm Electrical Activity (Edi) In Very Low Birth Weight (VLBW) Preterm Infants

Run by Sunnybrook Health Sciences Centre · NCT06295484 · Data updated 2026-11-12

This study is testing which breathing support method, CPAP or NIPPV, works better for very low birth weight preterm infants by comparing how their diaphragm functions while using each method.

Quick facts

Study typeInterventional
Ages1 Day to 8 Months
SexAll
Enrollment24 (estimated)
SponsorSunnybrook Health Sciences Centre
Academic / other
Locations1 site (Toronto, Ontario)
StatusRecruiting
StartedAugust 21, 2021
Main results expectedDecember 31, 2025
Study endsDecember 31, 2026
Registry record updatedMarch 6, 2024
Trial IDNCT06295484 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are clinically stable preterm infants with a birth weight of less than 1500 grams who are on nasal CPAP support.

Probably not a fit

Patients with congenital anomalies, significant neurological deficits, or ongoing treatment for sepsis may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to measure and compare diaphragm electrical activity in very low birth weight preterm infants requiring breathing support through either Continuous Positive Airway Pressure (CPAP) or Non-Invasive Positive Pressure Ventilation (NIPPV). The infants will be assigned to receive each method for two hours in a controlled setting, allowing researchers to monitor their respiratory function and stability. The study will involve routine monitoring of vital signs and will take place in the Neonatal Intensive Care Unit (NICU) at Sunnybrook Health Sciences Centre.

Why it matters

Potential benefit: If successful, this study could improve respiratory support strategies for preterm infants, potentially enhancing their recovery and long-term health outcomes.

How similar studies have gone: While the specific comparison of CPAP and NIPPV in this manner may be novel, similar studies have shown varying degrees of success in improving respiratory outcomes in preterm infants.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Clinically stable preterm infants (defined as cardiovascular stability with normal blood pressure and heart rate for gestational age and no recent increase in apneic episodes or spells and confirmed by the attending neonatologist)
* Birth weight less than 1500 grams
* Admitted to the NICU at Sunnybrook Health Sciences Centre on nasal CPAP of 5 to 8 cmH2O support, for at least 48 hours and requiring less than 35% of oxygen

Exclusion Criteria:

* Congenital anomalies of the gastrointestinal tract
* Phrenic nerve damage
* Diaphragmatic paralysis
* Esophageal perforation
* Congenital or acquired neurological deficit (including significant intraventricular hemorrhage greater than Grade II) or neonatal seizure
* Significant congenital heart disease (including symptomatic PDA)
* Congenital anomalies of the diaphragm
* Congenital anomalies of the respiratory tracts (e.g., Congenital Cystic Adenomatoid Malformation 'CCAM')
* Ongoing treatment for sepsis
* Ongoing treatment for necrotizing enterocolitis (NEC)
* Ongoing treatment for lung infections
* Narcotic analgesics
* Gastric motility agents
* Infants on nasal CPAP and requiring more than 35% oxygen
* Infants with significant gastric residuals and vomiting
* Infants with facial anomalies
* Infants with pneumothorax or pneumomediastinum
* Infants in the immediate postoperative period

Where it's running

  • Sunnybrook Health Sciences Center
    Toronto, Ontario, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.